PEOPLE - North American Scientific (US) makes appointment:
This article was originally published in Clinica
Radioisotopic products developer North American Scientific (Chatsworth, California) has expanded the product regulation activity of its Theseus Imaging subsidiary with the appointment of Robert Morgan as vice-president of regulatory affairs. Mr Morgan, who comes from Du Pont Pharmaceutical's medical imaging division, will work on the cardiology and oncology radiopharmaceutical candidate Apomate, among other products.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.